All data are based on the daily closing price as of December 24, 2024
a

ASKA Pharmaceutical Holdings

4886.TSE
13.15 USD
-0.04
-0.30%

Overview

Last close
13.15 usd
Market cap
372.61M usd
52 week high
16.73 usd
52 week low
10.25 usd
Target price
15.61 usd

Valuation

P/E
9.9417
Forward P/E
N/A
Price/Sales
0.9214
Price/Book Value
0.9125
Enterprise Value
334.47M usd
EV/Revenue
0.8261
EV/EBITDA
5.1684

Key financials

Revenue TTM
404.88M usd
Gross Profit TTM
167.85M usd
EBITDA TTM
58.25M usd
Earnings per Share
1.34 usd
Dividend
0.13 usd
Total assets
619.22M usd
Net debt
-35.50M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. ASKA Pharmaceutical Holdings Co.,Ltd. was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top